Nonpeptide neuromedin B receptor antagonists inhibit the proliferation of C6 cells

European Journal of Pharmacology

Volumn 409, Issue 2, 2000, Pages 133-142

  Moody, Terry W ^a   Jensen, Robert T ^b   Garcia, Luis ^a,b   Leyton, Julius ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

c fos mRNA; Ca2+; cytosolic; Focal adhesion kinase; Neuromedin B receptor antagonist; nonpeptide; Proliferation

Indexed keywords

2 [3 (2,6 DIISOPROPYLPHENYL)UREIDO] 3 (1H INDOL 3 YL) 2 METHYL N (1 PYRIDIN 2 YL CYCLOHEXYLMETHYL) PROPRIONATE; 3 (1H INDOL 3 YL) 2 METHYL 2 [3 (4 NITROPHENYL)UREIDO] N (1 PYRIDIN 2 YL CYCLOHEXYLMETHYL)PROPIONAMIDE; 3 (1H INDOL 3 YL) N [1 (5 METHOXYPYRIDIN 2 YL)CYCLOHEXYLMETHYL] 2 METHYL 2 [3 (4 NITROPHENYL)UREIDO]PROPIONAMIDE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTIMITOTIC AGENT; CALCIUM ION; FOCAL ADHESION KINASE; G PROTEIN COUPLED RECEPTOR; IODINE 125; MESSENGER RNA; NEUROMEDIN B; NEUROMEDIN B RECEPTOR; NEUROMEDIN B RECEPTOR ANTAGONIST; NEUROPEPTIDE RECEPTOR; PD 165929; PD 168368; PD 176252; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING COMPETITION; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CELL CULTURE; CELL PROLIFERATION; CLONOGENIC ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; DRUG RECEPTOR BINDING; FEMALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SECOND MESSENGER; TUMOR XENOGRAFT;

ANIMALS; BINDING, COMPETITIVE; CALCIUM; CELL DIVISION; CLONE CELLS; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; MICE; MICE, NUDE; NEUROKININ B; PROTO-ONCOGENE PROTEINS C-FOS; PYRIDINES; RECEPTORS, BOMBESIN; RNA, MESSENGER; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0034624267     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00828-1     Document Type: Article

References (43)

1. Isolation and amino acid sequences of alytesin and bombesin: two analogous active tetradecapeptides from the skin of European discoglossid frogs
2. 2) receptor antagonist
3. Molecular cloning of the bombesin/GRP receptor from Swiss 3T3 cells
4. Bombesin affects the central nervous system to produce hyperglycemia in rats
5. Bombesin, neuromedin C and neuromedin B given intrathecally facilitate the tail flick reflex in the rat
6. Bombesin-like peptides can function as autocrine growth factors in human small cell lung cancer
7. Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells
8. PD165929-the first high affinity non-peptide neuromedin B (NMB) receptor selective antagonist
9. The fifth transmembrane segment of the neuromedin B receptor is critical for high affinity neuromedin B binding
10. BRS-3: a novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells
11. CCK causes rapid tyrosine phosphorylation of p125FAK focal adhesion kinase and paxillin in rat pancreatic acini
12. Bombesin suppresses feeding in rats
13. Carboxyl-terminal modification of a gastrin releasing peptide derivative generates potent antagonists
14. Neuromedin B activates phospholipase D through both PKC-dependent and PKC-independent mechanisms
15. Bombesin activates MAP kinase in NSCLC cells
16. 13,14)Bombesin analogues inhibit the growth of small cell lung cancer in vitro and in vivo
17. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors
18. Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue
19. Bombesin induced behavioral changes: antagonism by neuroleptics
20. Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord
21. Bombesin/GRP and vasoactive intestinal peptide/PACAP as growth factors
22. Bombesin-like peptides elevate cytosolic calcium in small cell lung cancer cells
23. Human glioblastoma cell lines have neuropeptide receptors for bombesin/GRP
24. Neuromedin B receptors are present on small cell lung cancer cells
25. 4)
26. Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues
27. Different types of bombesin receptors on neurons in the dorsal raphe nucleus and the rostal hypothalamus in rat brain slices in vitro
28. Inhibition of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (FC-3093) and somatostatin analogue RC-160
29. Role of neuromedin B in the control of the release of throtropin in the rat
30. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells
31. Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD168368
32. A correlation of bombesin-responsiveness with myc-family gene expression in small cell lung carcinoma cell lines
33. Cloning and functional characterization of a cDNA encoding the murine fibroblast bombesin/GRP receptor
34. Distinct receptors mediate gastrin-releasing peptide and neuromedin B-induced delay of gastric emptying of liquids in rats
35. Properties and functions of a neuromedin B preferring bombesin receptor in brain microvascular endothelial cells
36. cDNA cloning, characterization and brain region-specific expression of a neuromedin-B preferring bombesin receptor
37. 2+ and phosphoinositides
38. Bombesin stimulates prolactin and growth hormone release by pituitary cells in culture
39. Characterization of bombesin receptors in a rat pituitary cell line
40. Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells
41. 11)substance P, a potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growth of human small cell lung cancer
42. A substance P antagonist also inhibits specific binding and mitogenic effects of vasopressin and bombesin-related peptides in Swiss 3T3 cells
43. Bombesin, vasopressin and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells: identification of a novel tyrosine kinase as a major substrate